High Grade Hepatotoxicity From Dual Checkpoint Inhibitors Is More Common in Hepatocellular Carcinoma Than Other Cancers
Related Posts
Rubin JB, Loeb R, Monto A, Wong RJ, Cheung R, Batki SL, Ostacher MJ, Shen H, Hoggatt KJ, Satre DD, Khalili M. COVID-19 Pandemic-Related Disruptions[...]
Gupta R, Chang C, Vergnes L, Sulaiman D, Yin F, Stewart JA, Mehrabian M, Kaufman JD, Jacobs JP, Lusis AJ, Reue K, Rosenfeld ME, Araujo[...]
Mercado-Gómez M, Goikoetxea-Usandizaga N, Giné AE, Merlos Rodrigo MA, Afonso MB, Azkargorta M, Zapata-Pavas LE, Rejano-Gordillo CM, Romero MR, Mendizabal I, Rodrigues PM, Wu H,[...]